drugset / Trial / NCT01076140

Blood Pressure Effects of Nebivolol Versus Lisinopril in New Onset or Worsening Hypertension Induced by Bevacizumab

NCT01076140

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to directly compare the blood pressure (hypertension) reduction effects of lisinopril and nebivolol in patients who develop new onset or worsening hypertension while treated with bevacizumab.

Timeline

Start
2010-02
Primary completion
2011-01
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator LISINOPRIL ANHYDROUS Small molecule 20 mg
Comparator LISINOPRIL ANHYDROUS Small molecule 40 mg
Comparator Nebivolol Other / unclassified 5 mg
Comparator Nebivolol Other / unclassified 10 mg

Indications